| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |